Ola Soderquist - 25 Oct 2024 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Reporting relationship: CFO, 10%+ Owner
Issuer ticker: BIXT
Reported as of: 25 Oct 2024
Net transaction value: +$5,557,698
SEC form: 4
Accepted by SEC: 28 Oct 2024, 17:29:49 UTC
Prior SEC filing: 20 Aug 2024
Source filing: View source filing
Reporting owner signature: Ola Soderquist

Key filing fact

Ola Soderquist filed Form 4 for BIOXYTRAN, INC (BIXT) on 28 Oct 2024.

Key facts

This page summarizes Ola Soderquist's Form 4 filing for BIOXYTRAN, INC (BIXT).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 Oct 2024, 17:29.

Change

Previous filing in this sequence was filed on 20 Aug 2024.
Current net transaction value: +$5,557,698.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIXT transaction

preferred

Other

Transaction value: $5,557,698
Shares: +10,197,611
Change %: +261%
Price: $0.5450
Shares after: 14,104,671
Date: 25 Oct 2024
Ownership: Direct
Footnotes: F1

BIXT transaction

preferred

Other

Transaction value: $500
Shares: -100,000
Change %: -0.71%
Price: $0.005000
Shares after: 14,004,671
Date: 25 Oct 2024
Ownership: Direct
Footnotes: F2

BIXT transaction

common

Other

Transaction value: $500
Shares: +500,000
Change %
Price: $0.001000
Shares after: 500,000
Date: 25 Oct 2024
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares were issued as payment for the sale of NDPD Pharma to Bioxytran

Footnote F2

A 1:5 exchange Preferred Stock (earlier issued under Section 16b-3) into shares of Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .